Hot Searches: Color Doppler Ultrasound Probe Puncture Rack
scroll down
Latest Products
2021-07-02
The COVID-19 pandemic has altered public medication purchasing and healthcare-seeking habits, driving rapid growth in the pharmaceutical e-commerce sector. Effective regulation and risk prevention will be key priorities moving forward. Recently, Li Danrong, Deputy Director of the Data Center at the Southern Institute of Pharmaceutical Economics, National Medical Products Administration, stated at the Jiangsu First Medical Device Informatization Development Summit and Jiangsu Medical Device Big Data Center Unveiling Ceremony that in 2020, online sales of pharmaceuticals reached 159.3 billion yuan, an increase of 59.1 billion yuan year-on-year, representing a 59% increase. The absolute value of online growth was more than three times that of offline sales.
2021-07-01
On June 29, SDAX Capital announced the launch of a US$400 million dedicated China healthcare fund ("SDAX Capital China Healthcare Fund V"). This fund will continue SDAX Capital's investment logic in China's healthcare sector, further deploying investments across the entire industry value chain, focusing on key disease areas, and establishing a comprehensive Chinese healthcare ecosystem. The fund will focus on early investment opportunities in China's healthcare industry, covering four sub-sectors: new drug development, medical devices and diagnostics, healthcare services, and medical IT/digital healthcare.
What did the digital transformation in the medical field look like in 2021?
2021-06-30
Like other industries, technology is advancing into the healthcare sector. The speed of medical innovation is driving the industry's digital transformation. Currently, better patient engagement and experience are needed. Furthermore, the data generated, tracked, analyzed, and used by innovative medical devices in real-time is the new currency of healthcare. In short, digital transformation is fostering R&D and improving operational performance, productivity, efficiency, and cost-effectiveness across the healthcare value chain.
Safeguarding Healthy Living Through Quality: Olympus Awarded the 2021 (Industry) Quality Model Award
2021-06-29
In the era of consumption upgrades, people's demands for the quality of goods and services are getting higher and higher, and various new products, new services, and new models are emerging rapidly. How to break through with quality has become a key issue that needs to be addressed in all industries. On June 24, the second International Quality Festival and the 2021 Consumer Leadership Summit were grandly opened in Beijing, with more than 300 excellent Brands from all over the world gathering here. At the meeting, Olympus won the "2021 (Industry) Quality Model Award".
In-depth Research on the In Vitro Diagnostics (IVD) Industry Under the COVID-19 Pandemic
2021-06-28
The IVD industry has attracted attention in the context of the COVID-19 pandemic. Since the end of 2019, the continued fermentation of the COVID-19 epidemic has put China's in vitro diagnostic industry on the front line of fighting the epidemic, and in a very short period of time, it has completed the development and research of diagnostic reagents, acting as a pioneer in the early diagnosis of diseases. The in vitro diagnostic industry has become one of the biggest highlights of this sudden public health event. In 2020, the social responsibility, sense of mission, and R&D innovation capabilities of Chinese IVD companies were fully demonstrated. Looking back at the long history of progress in the development of laboratory medicine, in prevention, diagnosis, and disease
2021-06-25
China's medical device industry has grown rapidly from small beginnings, and has now become a sunrise industry with a relatively complete range of products, continuously improving innovation capabilities, and strong market demand. In recent years, driven by the rapid growth in market demand for medical devices, the number of medical device manufacturing enterprises in China has steadily increased. Among them, Guangdong Province has the largest number of medical device manufacturing enterprises, while Jiangsu Province has the largest number of registered medical device products.
2021-06-24
On June 20, the Hainan Trade Port issued the "Hainan Free Trade Port Construction White Paper (2021)" for the first time, comprehensively showcasing the achievements of the Hainan Free Trade Port's construction in its first year and comprehensively explaining the major policies and measures implemented by Hainan to promote the construction of the Free Trade Port in the past year. In the field of industrial development, the pilot zone has achieved a breakthrough of more than 135 cases of imported special-use medicines and medical devices. The Ministry of Culture and Tourism, the National Health Commission, and the National Medical Products Administration are actively promoting the construction of the Boao Lecheng International Medical Tourism Pilot Zone. In terms of developing an outward-oriented economy, a pilot program for expanding the opening up of the service sector has been launched, focusing on key areas such as tourism, transportation, and medical health, and adopting a classified approach.
Contact Us
Room 618, 36 Gaoke Road, Tianhe District, Guangzhou, China
national unified free service hotline:400-020-6788
Copyright©2025 All Rights Reserved of Rencheng (Guangzhou) Medical Equipment Maintenance Co., Ltd.
